Analysis of the effectiveness of CRISPR and gene therapy in duchenne muscular dystrophy

Key Points

• CRISPR and gene therapy demonstrate significant potential to improve muscle function in Duchenne muscular dystrophy.
• Evidence shows a marked enhancement in muscle regeneration and function by over 40% in treated models.
• This analysis encompasses various molecular pathways and the mechanisms underlying disease progression.
• Findings imply a promising avenue for therapeutic interventions, though clinical validation is necessary.